Revenue Analysis, Competitive Landscape and Outlook

1.9.2023 : G-Protein Coupled Receptors (GPCRs) Market Expected to Reach USD 5.10 Billion by 2029, with 6.7 % CAGR

G-Protein Coupled Receptors (GPCRs) Market Report Scope and Research Methodology

Report Scope:

The newly released G-Protein Coupled Receptors (GPCRs) Market Research Report provides comprehensive insights into this dynamic market. It encompasses a detailed analysis of market dynamics, including drivers and restraints, regional insights, and segment-specific evaluations.

Research Methodology:

Our report employs a rigorous research methodology, combining primary and secondary data sources. Extensive data collection, analysis, and validation procedures ensure the accuracy and reliability of our findings. Industry experts, key market players, and thorough data analytics contribute to the robustness of our research.

For detail insights on this market, request for methodology here @ : https://www.maximizemarketresearch.com/market-report/global-g-protein-coupled-receptors-gpcrs-market/104389/

What are G-Protein Coupled Receptors (GPCRs) Market Dynamics?

Market Drivers:

The primary driver of the G-Protein Coupled Receptors (GPCRs) Market is the escalating prevalence of cancer worldwide. This market growth is further propelled by the increasing incidence of lifestyle-related diseases, such as cardiovascular disorders and respiratory ailments. GPCRs play a crucial role in the development of innovative pharmaceuticals, making them indispensable in the medical landscape. Additionally, augmented government funding for research and development initiatives in drug discovery bolsters market expansion.

The availability of a diverse range of licensed pharmaceuticals targeting GPCRs is contributing significantly to market growth. In 2021, approximately 700 medications targeting GPCRs received approval, indicating a growing demand for associated assays. This demand is driven by the emergence of allosteric modulators, biologic drugs, and biased agonists targeting GPCRs.

Advancements in computational approaches, simplifying receptor structure for successful drug discovery, are another driving force. Researchers have harnessed computational techniques to create thermally stable GPCRs for drug formulation, exemplifying the potential for innovation in this field.

Market Restraints:

Despite the promising prospects, the high cost of GPCRs cell lines poses a substantial obstacle to market growth. Unfavorable reimbursement regulations, especially in developing markets, compound these challenges. Additionally, the scarcity of qualified individuals and expertise may further restrain market growth.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ : https://www.maximizemarketresearch.com/request-sample/104389

G-Protein Coupled Receptors (GPCRs) Market Segmentation?

The cAMP Assays category held the most market share in 2022 when it came to Assay Type. The cAMP assays market category dominated the global market because cyclic Adenosine Monophosphate (cAMP) is a crucial intracellular second messenger in GPCR signal transduction. The availability of a wide product selection for reagent kits to measure cAMP messenger levels is also advancing the sector. The calcium level detection assays market is anticipated to expand at a lucrative CAGR during the forecast period as a result of the advantages of using calcium flux assays, such as high sensitivity, ease in estimating calcium flux, and user configurability.

During the forecast period, the oncology segment is anticipated to rule the global market. With over 700 genes found, G-protein coupled receptors are the largest protein superfamily in the human genome. GPCRs play a role in a variety of physiological processes, including hormone responses and sensory modulation. Thanks to a focus on basic and clinical research, it has recently been demonstrated that signalling through GPCRs affects a number of aspects of cancer biology, including invasion, migration, and vascular remoulding. Additionally, it has been found that some cell types express over 150 distinct GPCRs, one of which is expressed quite strongly. This supports industry-wide biomarker-based research and opens the door to the creation of lead candidates that specifically target GPCRs.

Who are G-Protein Coupled Receptors (GPCRs) Market Key Players?

• Thermo Fisher Scientific, Inc.
• Becton, and Dickinson and Company
• Abcam plc.
• Enzo Life Sciences, Inc.
• Promega Corporation.
• PerkinElmer Inc.
• QIAGEN
• Merck KGaA
• HD Biosciences Co., Ltd
• Cisbio Bioassays
• Eurofins DiscoverX Products.
• Actelion Pharmaceuticals Ltd
• Accure Pharma
• Anchor Therapeutics.
• Arena Pharmaceuticals, Inc.
• ADDEX THERAPEUTICS
• WuXi AppTec
• BioInvenu, Inc.
• Molecular Devices, LLC.
• Corning Incorporated

Please connect with our representative, who will ensure you to get a report sample here @ : https://www.maximizemarketresearch.com/request-sample/104389

Regional Insights:

North America: In 2022, North America dominated the global G-Protein Coupled Receptors (GPCRs) Market. This leadership is attributed to strategic investments in cancer research, the approval of GPCR-targeted drugs, and intensified focus on drug discovery and development. Regulatory approvals in the United States and the European Union have propelled the market forward, with 128 targets listed in the FDA orange book.

APAC: The Asia-Pacific (APAC) region is poised for lucrative market growth during the forecast period. Factors contributing to this growth include the economic development of countries like China and India, increased government investments in biotechnology and biopharmaceuticals, rising life expectancy, growing per capita income, and unmet market needs. The presence of emerging firms like Sosei Heptares and NB Health Laboratory positions APAC as the fastest-growing regional market.

Key Offerings:

Past Market Size and Competitive Landscape (2018 to 2021)
Past Pricing and price curve by region (2018 to 2021)
Market Size, Share, Size & Forecast by different segment | 2022-2029
Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by region
Market Segmentation - A detailed analysis by Product
Competitive Landscape - Profiles of selected key players by region from a strategic perspective
Competitive landscape - Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of business by region
Lucrative business opportunities with SWOT analysis
Recommendations
Related Reports:

Global Electrochromic Glass Market : https://www.maximizemarketresearch.com/market-report/global-electrochromic-glass-market/30131/

Global Visualization and 3D Rendering Software Market : https://www.maximizemarketresearch.com/market-report/global-visualization-3d-rendering-software-market/7572/

Global Virtual Kitchen Market : https://www.maximizemarketresearch.com/market-report/global-virtual-kitchen-market/66705/

Global Ultrafiltered Milk Market : https://www.maximizemarketresearch.com/market-report/global-ultrafiltered-milk-market/69717/

Indian Food and Beverages Market : https://www.maximizemarketresearch.com/market-report/indian-food-and-beverages-market/29426/

Processed Animal Protein Market : https://www.maximizemarketresearch.com/market-report/processed-animal-protein-market/148162/

Contact Maximize Market Research:

MAXIMIZE MARKET RESEARCH PVT. LTD.

444 West Lake Street, Floor 17,

Chicago, IL, 60606, USA.

+1 800 507 4489 +91 9607365656

sales@maximizemarketresearch.com

www.maximizemarketresearch.com

About Maximize Market Research:

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.